Current technologies can enable real time access to expert pathology specialists for case review and 2nd opinions and are particularly valuable for patients in areas where specialists are in short supply. But other barriers to widespread adoption of these technologies remain. One of the key issues that must be addressed to spur that adoption is remote licensing for specialists.
